FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2772372009> ?p ?o ?g. }

• W2772372009 endingPage "e0189210" @default.
• W2772372009 startingPage "e0189210" @default.
• W2772372009 abstract "Vaccination for hepatitis A virus (HAV) has been implemented as one of the national vaccination programs despite the epidemiological transition of HAV in the Republic of Korea. While the national HAV vaccination program is largely associated with the shift of socioeconomic trend in the country, concerns have been raised on the effectiveness of the HAV immunization. The objective of this study was to examine the epidemiological trend of HAV and assess the effectiveness of the nationwide HAV vaccination policy based on a nationally representative sample of the Korean population collected in 2015.We analyzed anti-HAV of 5,856 respondents aged ≥10 years collected from Korean National Health and Nutrition Examination Survey (KNHANES) data in 2015. We estimated age-adjusted anti-HAV prevalence by sociodemographic and other characteristics. We evaluated the factors associated with anti-HAV positivity among each age group (10-19, 20-29, 30-45 and over 45 years old).The prevalence of anti-HAV among adults aged ≥10 years was 72.5% (95% confidence interval, CI, 73.7-71.4) in 2015. The lowest age-specific prevalence was among adults aged 20-29 years with 11.9% (95% CI 9.3-15.1%). The prevalence of anti-HAV among those aged 10-14 and 15-19 years was 59.7% (95% CI 52.7-66.4) and 24.0% (95% CI 19.5-29.3), respectively. The prevalence of anti-HAV among adults aged between 30 and 44 years rapidly increased from below 20% to above 90%. The prevalence of anti-HAV among adults aged ≥45 years was 97.8% (95% CI 96.0-97.6). Factors significantly associated with anti-HAV positivity among those aged 10-19 years old were young age, higher house income and high influenza vaccination rate. Compared to the respondents aged 10-19 years (those who were subject to the national childhood vaccine recommendation), those aged 20-29 years (those who were not subject to the recommendation) had low adjusted odds ratio (OR, 0.52 95% CI 0.34-.81 P-value = 0.004) for anti-HAV positivity.The age-adjusted anti-HAV prevalence showed a U-shaped association, implying the high dependence of anti-HAV prevalence on age and the epidemiological shift. The inclusion of the hepatitis A vaccine into the national immunization recommendation was effective shown by the increase of immunity in the general population. However, the vaccination rate was low in the low-income group. Young adults aged 20-39 years may benefit from inclusion in the HAV vaccination program due to the significantly low vaccination rate." @default.
• W2772372009 created "2017-12-22" @default.
• W2772372009 creator A5035047849 @default.
• W2772372009 creator A5051694555 @default.
• W2772372009 creator A5059710776 @default.
• W2772372009 creator A5066036654 @default.
• W2772372009 date "2017-12-08" @default.
• W2772372009 modified "2023-09-24" @default.
• W2772372009 title "The effectiveness and limitation of the national childhood hepatitis A vaccination program in the Republic of Korea: Findings from the Korean National Health and Nutrition Examination Survey (KNHANES), 2015" @default.
• W2772372009 cites W14283252 @default.
• W2772372009 cites W149518630 @default.
• W2772372009 cites W1748861715 @default.
• W2772372009 cites W1971502089 @default.
• W2772372009 cites W1972962464 @default.
• W2772372009 cites W2002202468 @default.
• W2772372009 cites W2005721346 @default.
• W2772372009 cites W2011947723 @default.
• W2772372009 cites W2017974516 @default.
• W2772372009 cites W2018237395 @default.
• W2772372009 cites W2020461577 @default.
• W2772372009 cites W2027545991 @default.
• W2772372009 cites W2045158324 @default.
• W2772372009 cites W2049115312 @default.
• W2772372009 cites W2052721979 @default.
• W2772372009 cites W2068374624 @default.
• W2772372009 cites W2069487512 @default.
• W2772372009 cites W2074261782 @default.
• W2772372009 cites W2111799124 @default.
• W2772372009 cites W2123836034 @default.
• W2772372009 cites W2126280850 @default.
• W2772372009 cites W2131735754 @default.
• W2772372009 cites W2132098870 @default.
• W2772372009 cites W2152899938 @default.
• W2772372009 cites W2159917334 @default.
• W2772372009 cites W2166430891 @default.
• W2772372009 cites W2169267861 @default.
• W2772372009 cites W2169394413 @default.
• W2772372009 cites W2186140012 @default.
• W2772372009 cites W2230632262 @default.
• W2772372009 cites W2426941292 @default.
• W2772372009 cites W2553123861 @default.
• W2772372009 cites W2578123310 @default.
• W2772372009 cites W2591787377 @default.
• W2772372009 cites W2613925801 @default.
• W2772372009 cites W4300947929 @default.
• W2772372009 doi "https://doi.org/10.1371/journal.pone.0189210" @default.
• W2772372009 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5722338" @default.
• W2772372009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29220416" @default.
• W2772372009 hasPublicationYear "2017" @default.
• W2772372009 type Work @default.
• W2772372009 sameAs 2772372009 @default.
• W2772372009 citedByCount "3" @default.
• W2772372009 countsByYear W27723720092019 @default.
• W2772372009 countsByYear W27723720092020 @default.
• W2772372009 countsByYear W27723720092022 @default.
• W2772372009 crossrefType "journal-article" @default.
• W2772372009 hasAuthorship W2772372009A5035047849 @default.
• W2772372009 hasAuthorship W2772372009A5051694555 @default.
• W2772372009 hasAuthorship W2772372009A5059710776 @default.
• W2772372009 hasAuthorship W2772372009A5066036654 @default.
• W2772372009 hasBestOaLocation W27723720091 @default.
• W2772372009 hasConcept C107130276 @default.
• W2772372009 hasConcept C126322002 @default.
• W2772372009 hasConcept C144024400 @default.
• W2772372009 hasConcept C149923435 @default.
• W2772372009 hasConcept C187212893 @default.
• W2772372009 hasConcept C203014093 @default.
• W2772372009 hasConcept C22070199 @default.
• W2772372009 hasConcept C2775876817 @default.
• W2772372009 hasConcept C2776029263 @default.
• W2772372009 hasConcept C2779874844 @default.
• W2772372009 hasConcept C2780799908 @default.
• W2772372009 hasConcept C2908647359 @default.
• W2772372009 hasConcept C44249647 @default.
• W2772372009 hasConcept C71924100 @default.
• W2772372009 hasConcept C99454951 @default.
• W2772372009 hasConceptScore W2772372009C107130276 @default.
• W2772372009 hasConceptScore W2772372009C126322002 @default.
• W2772372009 hasConceptScore W2772372009C144024400 @default.
• W2772372009 hasConceptScore W2772372009C149923435 @default.
• W2772372009 hasConceptScore W2772372009C187212893 @default.
• W2772372009 hasConceptScore W2772372009C203014093 @default.
• W2772372009 hasConceptScore W2772372009C22070199 @default.
• W2772372009 hasConceptScore W2772372009C2775876817 @default.
• W2772372009 hasConceptScore W2772372009C2776029263 @default.
• W2772372009 hasConceptScore W2772372009C2779874844 @default.
• W2772372009 hasConceptScore W2772372009C2780799908 @default.
• W2772372009 hasConceptScore W2772372009C2908647359 @default.
• W2772372009 hasConceptScore W2772372009C44249647 @default.
• W2772372009 hasConceptScore W2772372009C71924100 @default.
• W2772372009 hasConceptScore W2772372009C99454951 @default.
• W2772372009 hasIssue "12" @default.
• W2772372009 hasLocation W27723720091 @default.
• W2772372009 hasLocation W27723720092 @default.
• W2772372009 hasLocation W27723720093 @default.
• W2772372009 hasLocation W27723720094 @default.
• W2772372009 hasOpenAccess W2772372009 @default.
• W2772372009 hasPrimaryLocation W27723720091 @default.

• next